How States Use Cost-Growth Benchmark Programs to Contain Health Care Costs
/in Health System Costs Connecticut, Delaware, Massachusetts, Rhode Island, Washington Charts, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark /by Deborah Fournier and Adney RakotoniainaWhat’s New in NASHP’s Updated Hospital Cost Calculator?
/in Policy Blogs, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark /by Adney Rakotoniaina and Marilyn BartlettSlide Deck: Understanding the Health Care Cost Conundrum in 2020
/in Health System Costs Consumer Affordability, Cost, Payment, and Delivery Reform, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark, Value-Based Purchasing Health System Costs /by Johanna ButlerTo help state policymakers engage in difficult discussions around how best to lower the health care cost trajectory, the National Academy for State Health Policy created the slide deck, Understanding the Health Care Cost Conundrum in 2020, featuring factual information about rising health care costs.
This toolbox features multiple sections that could be used together or featured separately by topic depending on a state’s interests. Addressing health care costs can be a complex and monumental task, this new resource provides a straightforward, easy-to-understand overview to help inform policymakers and the public.
NASHP Slide Deck Helps Policymakers Understand the Health Care Cost Conundrum
/in Health System Costs Blogs, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark /by Johanna ButlerCOVID-19 and its impact on states’ economies and budgets has refocused attention on high health care costs. To help state policymakers engage in the difficult discussions around how best to lower the health care cost trajectory, the National Academy for State Health Policy (NASHP) created the slide deck Understanding the Health Care Cost Conundrum in 2020 to help policymakers understand what is leading to rising health care costs and make the case for action.
Building on a range of recent research, NASHP’s slide deck is a toolbox for state officials – it is made up of multiple sections that focus on different parts of the cost challenge and can be presented together or by section depending on a state’s goals.
It provides a helpful overview to break down rising health care costs, including information about total US health care spending, the expected costs of COVID-19, and a primer about what’s driving spending.

Addressing health care costs can be a monumental task for state policymakers and is complicated by the complex and biased information provided by different actors across the health care industry. This new resource is designed to provide a straightforward, easy-to-understand overview that will resonate with policymakers and the public.
The slide deck is designed to prompt discussion about important questions, such as:
- What if states could dedicate some of the resources now going towards direct health care costs to other priorities, such as investing in social determinants of health or working to achieve health equity?
- How will COVID-19 contribute to additional health care consolidation, a key driver of high costs?
- How do high costs impact consumers, employers, and the overall economy?
The slide deck also includes an infographic showing hospitals’ many funding sources and highlights how the burden of high costs falls on individuals in multiple ways – in their roles as taxpayers, employees, employers, and consumers.
View more state tools to address health care costs at NASHP’s Center for Health System Costs’ model legislation and resources.
How States Can Advance Health Equity while Addressing Health System Costs
/in Health System Costs, Policy Blogs, Featured News Home Accountable Health, Chronic Disease Prevention and Management, Community Benefit, COVID-19, Health Equity, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Population Health, Quality and Measurement, Social Determinants of Health, Total Cost of Care Benchmark /by Adney RakotoniainaStates have long faced budget limitations, a history of systemic racism, and a mandate to contain costs while maintaining access to quality care. COVID-19 has exacerbated these issues as state revenues decline and communities of color are disproportionately impacted by the pandemic. These challenges raise an important question – how does a state advance health equity while addressing health system costs?
The rising cost of health care has created an additional barrier to accessing quality care, particularly for racial/ethnic minorities. In 2018, 13 percent of White patients reported going without needed care due to its prohibitively high cost. For nearly every other racial/ethnic group, this number ranged from 17 to 21 percent.
One contributing factor is that people of color are disproportionately uninsured. Not only are the uninsured solely responsible for their medical costs, but they are charged a higher rate for their care without the advantage of an insurer’s negotiated pricing with providers. Additionally, as millions of people have lost insurance coverage due to pandemic-related job loss, there remains a clear need for strategies that lower health care system costs rather than simply through insurance coverage.
Leveraging Payment Systems to Enable Community Investments
One such strategy discussed by state leaders at the National Academy for State Health Policy’s (NASHP) recent annual conference is a global hospital budget approach. Under this system, a state works with a hospital to determine the hospital’s allowed revenues for the year. As implemented in Maryland, a hospital’s deviation from its allowed revenues – whether by surplus or deficit – by more than a narrow 0.5 percent margin resulted in penalties against the hospital’s budget the following year.
Through this approach, a state offers predictable payments to hospitals and incentivizes them to avoid excess costs. While fee-for-service hospitals across the country express concerns of closures due to unpredictable revenue from the pandemic-related pause in elective procedures, participating global budget hospitals in Maryland have been able to rely on more consistent revenue despite a decline in care utilization.
This predictability better enables hospitals to retain revenue and invest those funds within the community to address the upstream determinants of health, as required of tax-exempt hospitals under community benefit laws. While research shows the majority of nonprofit hospitals do not address health disparities in their investments, Maryland is one of the states working to pivot hospital investments to meet equity goals. Maryland requires nonprofit hospitals to submit an annual report that includes a list of its community benefit initiatives and the cost of each one.
At NASHP’s conference, Katie Wunderlich, executive director of the Maryland Health Services Cost Review Commission, described a Baltimore hospital that has reduced its inpatient footprint and increased its spending on substance use disorder counseling, a healthy food market, and job training. Investments in the socioeconomic resources needed to foster good health (such as healthy housing, nutritious food, and sufficient income) are particularly important in communities of color, which have been historically deprived of these resources.
Just as global budgets enable hospitals to invest retained revenue in their communities, a growing number of states are utilizing cost-growth benchmark programs to avoid unnecessary public spending on health care, which can instead be invested in services beyond the scope of clinical care.
Utilizing Cost-Containment Strategies to Improve Chronic Care Management
While acute care provided in clinical settings is important for improving health, chronic conditions such as cardiovascular disease and cancer encompass a growing share of patient care needs and costs, particularly for patients of color. Managing these conditions – and preventing the costly care associated with them – require the engagement of the state, public and commercial payers, hospital and non-hospital providers, and community organizations alike.
Cost-growth benchmarks, in which a state sets a limit on annual per capita health spending growth, operate statewide and engage all stakeholders in managing a state’s total cost of care. State leaders can also use these as tools to improve health outcomes by including quality benchmarks.
Multiple entities work with the state oversight agency to set and meet these cost and quality benchmarks statewide, enhancing transparency, efficiency, and shared accountability for health care spending and quality. When it created its benchmark program through an executive order, Delaware established eight quality benchmarks, including:
- Adult obesity – A long-term benchmark of no more than 27.4 percent of adults with a body mass index greater than or equal to 30 kg/m2.
- Physical activity among high school students – A long-term benchmark of at least 48.7 percent of students engaging in physical activity for greater than or equal to 60 minutes per day five days a week.
- Statin therapy for patients with cardiovascular disease – A long-term benchmark of 82.1 percent of commercially insured and 68.3 percent of Medicaid-enrolled, at-risk individuals adhering to medication compliance greater than or equal to 80 percent of the treatment period.
- Persistence of beta blocker treatment after a heart attack – A long-term benchmark of 91.9 percent of commercially insured and 83.9 percent of Medicaid-enrolled individuals age 18 and older receiving beta-blockers for six months after discharge
Similarly, Maryland’s new total cost-of-care model seeks to reduce the burden of chronic disease – particularly diabetes – through a focus on chronic care management. The goal is to help providers pay specific attention to and provide additional resources for communities disproportionately affected by chronic diseases.
While meeting these statewide benchmarks would not inherently address equity issues within these health outcomes, the inclusion of these quality benchmarks can contain costs through effective management and prevention of chronic conditions. In turn, it would reduce health care spending among Black and Latinx adults as they are the most likely to suffer from cardiovascular disease risk factors, such as hypertension and obesity. As racial/ethnic minorities disproportionately lack health insurance coverage, it is crucial to prevent the development of inequitable health outcomes before costly clinical care intervention is needed, in addition to effectively managing these conditions in clinical settings.
As racial and ethnic minorities disproportionately lack health insurance coverage, it is crucial to prevent the development of inequitable health outcomes before costly clinical care intervention is needed, in addition to effectively managing these conditions in clinical settings.
Moving forward, states can use global budgets and cost-growth benchmarks as strategies to advance health equity while addressing health system costs. As states search for ways to better ingrain health equity into payment systems, these strategies offer states the ability to retain much needed revenues, focus upstream spending in non-clinical settings, better enable hospital community benefit spending, and manage chronic conditions that disproportionately impact people of color.
NASHP will be following the cost and health equity implications of these, and other, state efforts. For additional tools to help address health system costs, explore NASHP’s Model Act to Ensure Financial Transparency in Hospitals and Health Care Systems, designed to help state policymakers and the public access detailed hospital financial information to better analyze a hospital’s assets as well as its expenses and liabilities. Additionally, NASHP is also following state efforts to address health inequities highlighted by COVID-19.
Why Compare What Employers Pay to What Medicare Pays?
/in Health System Costs Blogs, Featured News Home Consumer Affordability, Health System Costs, Hospital/Health System Oversight, Making the Case for Action, Total Cost of Care Benchmark Hospital/Health System Oversight, State Employee Health Plans /by Adney Rakotoniaina, Marilyn Bartlett and Trish RileyResults from a new RAND Corporation study – Nationwide Evaluation of Health Care Prices Paid By Private Health Plans – show commercial payers reimburse hospitals about 2.5-times more than does Medicare. As expected, hospital officials responded, claiming that public payers underpay for medical services and that it is inappropriate to challenge hospitals now as they battle the pandemic. However, the RAND study revealed a very significant finding – there is no relationship between a hospital’s prices charged to commercial payers and its volume of Medicare and Medicaid patients.
There is never a good time to take on hospital prices, but that task is essential if the nation is ever to get a grip on health care costs. Hospitals are large employers and provide an essential service, never more important than during the pandemic, but they also comprise the biggest chunk of health care spending, driving up insurance premiums and out-of-pocket costs.
Additionally, most hospital markets are now consolidated, creating an imbalance in bargaining power and driving up costs. A growing trend in vertical consolidation – when hospital/heath care systems purchase physician practices and other ancillary services – has resulted in increased costs, in part through the addition of facility fees for non-hospital-based services.
Policymakers are often pressured to protect their local hospitals and avoid the much-needed discussion of what is an adequate payment to sustain quality hospital care. The RAND study provides a great place to start that discussion and the first step is understanding just how Medicare sets its rates. The National Academy for State Health Policy (NASHP) offers this overview on Medicare rates and will soon release more tools to help states take on the important policy question of what is an appropriate hospital payment.
How Are Medicare Rates Calculated?
Since the passage of the Social Security Amendments Act of 1983 that created Medicare, the federal health insurance program covering 40 million older and/or disabled adults has primarily reimbursed providers through prospective fee-for-service (FFS) payments. Under the federal Prospective Payment System (PPS), Medicare reimburses each provider a predetermined amount for each service.
Medicare Advantage plans – established in 1997 as privately administered alternatives to traditional Medicare – are a notable exception from the standard FFS system. For these plans, the Centers for Medicare & Medicaid Services (CMS) pays a private health plan a prospective lump sum based on the number of beneficiaries enrolled in the plan. The health plan then uses these funds to reimburse providers and administer benefits to enrollees.
Medicare payments to some plans are negotiated from a benchmark based on a county’s per capita Medicare spending compared to the national average, as well as plan quality indicators. For other plans, the benchmark is a weighted average of the average county rate and the average health plan’s bid. CMS publishes the statutorily derived formulas for these payments.
Under the PPS for inpatient admissions, CMS bases the amount of reimbursement on a patient’s diagnosis-related group (DRG). Each patient’s case is assigned a different DRG code based largely on five main factors, including the type and severity of their illness. Generally, the more resources (e.g., medical supplies) required to treat a patient, the greater the reimbursement. This amount can vary based on local wages and cost of living, and additional payments are made to teaching hospitals and those that treat a high percentage of low-income patients.
Under the PPS for hospital outpatient services, payments are similarly based on resource costs and complexity. Additionally, hospitals can receive payments for using certain new drugs/devices, providing particularly costly services, or if the hospital is a cancer, children’s, and/or rural hospital. To determine these reimbursement rates, CMS receives recommendations from an advisory panel of 16 full-time hospital employees and outpatient PPS providers.
An important recurring factor in CMS’s payment methodology is its consideration of stakeholder recommendations. Under the Resource-Based Relative Value Scale (RBRVS) FFS payment system, CMS considers recommendations from a 31-member physician committee when quantifying the value of each service rendered, based on the following geographically adjusted costs:
- Physician work – the time, skill, and mental/physical effort required to perform the service
- Practice expense – the cost for the service to be rendered at the specific site of care
- Professional liability insurance – the amount a provider spends on malpractice insurance, based on claims data
The Medicare Payment Advisory Commission (MedPAC) – the independent 17-member Congressional advisory commission of health care delivery and finance experts – meets publicly with beneficiary advocates, researchers, and providers to consider their input before submitting an annual report to Congress detailing the payment adequacy in meeting patient care and provider cost needs, in addition to considering any inequities that may result from payments.
According to MedPAC’s March 2020 report, Medicare payments covered 8 percent more than hospitals’ allowed variable costs (costs that can change based on utilization of services), which allows for this additional percentage to contribute to coverage of fixed costs. This method provides incentive for hospitals to lower their costs and encourages them to treat Medicare beneficiaries, as an increase in the number of patients a hospital treats results in an increased contribution to fixed costs while covering variable costs.
Medicare payments are determined in part through these various stakeholder recommendations. However, this input is not the sole means by which Medicare rates are set. CMS also collects quantitative data through the Medicare cost report, which is the primary data collection to assess provider costs.
How Does CMS Collect Provider Cost Data?
The costs that a provider’s PPS reimbursement are based on are collected through a publicly available Medicare cost report (MCR). These annual reports, due five months after a fiscal year ends, are required from all Medicare-reimbursable facilities, including hospitals, skilled nursing homes, home health agencies, home offices, hospices, rural health clinics, federally qualified health centers, and comprehensive outpatient rehabilitation facilities.
Each report includes information on hospital revenues, capacity, discharge volume, charges, and operating costs. To ensure accuracy, an officer or administrator of the hospital must certify the reported data complies with relevant laws and regulations and that the MCR is a “true, correct, and complete statement.” These reports are the only national source for hospital operating costs reported in a uniform manner.
Critics argue that the definition of allowable costs under federal code 42 CFR 413.9(c)(3) is too narrow, classifying what some might say are appropriate costs as non-reimbursable. However, only operating costs related to patient care are reimbursable under the program. If operating costs include amounts for “luxury items or services” (more expensive than those generally considered necessary for the provision of needed health services), such amounts are not allowable.
Physician costs are often the largest “disallowed” appropriate costs, according to critics. However, while some of these costs are disallowed by Medicare through the inpatient/outpatient PPS, this is only because they are reimbursed through other payment methods. The MCR splits physician costs into three buckets:
- Non-reimbursable services: These services, of which research is the most common component, are disallowed as they do not provide patient care and are usually reimbursed by other funding.
- Professional services to individual patients: These costs are disallowed as professional service reimbursement is provided through other channels, such as RBRVS, Medicaid/Medicare fee schedules, and commercial network agreements, etc.
- General services that provide benefit to hospital patients: These costs are allowed and reimbursed under the MCR. General services may include emergency room, intensive care unit, and other areas of general care that are not reimbursed through another channel.
The transparency surrounding these allowed and disallowed costs enables states to use tools such as NASHP’s upcoming Hospital Cost Calculator, which utilizes data from MCRs to provide a comprehensive view of a hospital’s financial status. This can inform a state’s provider reimbursement negotiations and other cost-containment strategies.
Building on the Progress
Medicare rates are based on provider-attested costs while allowing for a transparent, standard payment system that can evolve. For example, the Medicare Access and Children’s Health Insurance Program Reauthorization Act of 2015 (MACRA) reformed Medicare to replace the population growth-rate based spending cap with two pathways – the Merit-based Incentive Payment System and the Advanced Alternative Payment Models – to base providers’ reimbursements on their performance against various quality and cost measures.
The methodology of Medicare rate determination is annually updated, geographically adjusted, and publicly available through the CMS website that also publishes a complete listing of fees used to pay providers/medical equipment suppliers and a regularly updated tool that allows users to estimate PPS payments based on claims data and provider cost reports.
Multiple stakeholder groups have helped Medicare, the largest health care purchaser in the country, promote equity and transparency in covering nearly every service and paying for health system costs rather than charges.
A hospital does not have to abide by any formula or legal requirement for setting its charges nor does it have to disclose mark-ups on hospital-purchased services or medical supplies, and it may change them at any time. As a result, chargemaster rates (what hospitals list as prices for their services) present an inaccurate benchmark for assessing costs and negotiating reimbursements between commercial payers and providers, resulting in costly bills for patients.
However, when the transparent and standardized Medicare rates are used as the benchmark, states can achieve savings while still covering providers’ costs and they can better explore innovative strategies to improve health care affordability.
Massachusetts Gov. Charlie Baker Is NASHP’s 2020 Annual Conference Keynote Speaker
/in #NASHPCONF20 Blogs, Featured News Home Consumer Affordability, COVID-19, Health Equity, Health System Costs, Hospital/Health System Oversight, Population Health, Total Cost of Care Benchmark /by NASHP StaffMassachusetts Gov. Charlie Baker will kick off the National Academy for State Health Policy’s 33rd annual conference with a keynote address at 4:30 p.m. (ET) Monday, Aug. 14, 2020. The conference, originally scheduled for Boston, will be delivered on-line.
Massachusetts has long been a national health reform leader and Gov. Baker has played a key role in many advances since his election in 2015. Previously, he served 10 years as CEO of the non-profit Harvard Pilgrim Health Care, which the National Committee for Quality Assurance repeatedly ranked as the nation’s top-ranked health plan during his tenure. Earlier, Gov. Baker held key positions in Massachusetts state government as Secretary of Health and Human Services and Secretary of Administration and Finance.
Gov. Baker is leading Massachusetts through the COVID-19 pandemic and has prioritized testing and contact tracing programs. His administration implemented reforms at the state’s health exchange, the Massachusetts Health Connector. Massachusetts currently leads the nation in health insurance coverage with only 3 percent of its population uninsured.
Last year, Gov. Baker introduced An Act to Improve Health Care by Investing in VALUE, designed to deliver more cost effective, nimble, and patient-centric health care for the 21st century. A cornerstone of the comprehensive plan is a significant investment in primary care and behavioral health, while maintaining the state’s cost growth targets administered by the state’s Health Policy Commission. That first-in-the-nation, cost-growth benchmarking system has reported success in bending the health care cost trajectory and other states are now replicating it.
Baker’s newest proposal for the plan would add enforcement provisions that require health care providers who exceed the target to pay fines. The proposal, which the state Legislature is currently deliberating, also includes provisions to lower pharmaceutical costs, including subjecting manufacturers who raise drug prices excessively to fines and redirecting those revenues to support community hospitals and safety net providers.
Register for NASHP’s annual conference, State Health Policy: Flexibility and Resiliency through COVID-19 and Beyond, on Aug. 17-19, 2020.
Connecticut Governor Sets Health Care Cost and Quality Benchmarks
/in Policy Connecticut Blogs, Featured News Home Health System Costs, Total Cost of Care Benchmark /by Chris KukkaLast week, Gov. Ned Lamont signed two executive orders that establish health care cost growth and quality benchmarks and require more transparency of Medicaid costs and quality. The benchmarks are similar to ones Massachusetts implemented, which has helped Bay State consumers avoid more than $5 billion in costs since 2013.
“Gov. Lamont’s initiative directly addresses the high costs of health care that are driving up premium rates and consumers’ out of pocket exposure,” observed Trish Riley, executive director of the National Academy for State Health Policy. “Connecticut joins Massachusetts, Rhode Island, and Delaware in launching this comprehensive approach to limit the growth of health care costs in the states and is well positioned to lead given the expertise and focus in the Office of Health Strategy.”
While Connecticut ranks sixth nationwide in health care quality, its costs are high, also ranking sixth across the country. Over the past 15 years, families saw the cost of health care rise by 77 percent, while median wages rose only 21 percent. The governor’s two executive orders are designed to accomplish the following.
Executive Order No. 5 directs the Office of Health Strategy (OHS) to:
- Develop annual cost growth benchmarks by December 2020 for calendar years 2021-2025;
- Establish targets for increased primary care spending to reach 10 percent of total health care spending by 2025;
- Develop quality benchmarks for all public and private payers beginning in 2022;
- Monitor and report annually on health care spending growth across public and private payers;
- Convene a cost benchmark technical advisory team within 30 days; and
- Monitor accountable care organizations and the adoption of alternative payment models.
Executive Order No. 6 directs Department of Social Services (DSS) to convene an advisory board to bolster efforts to control Medicaid costs – which account for more than 20 percent of state expenditures – and increase quality of care standards and reduce disparities. DSS must:
- Develop a transparency strategy for Medicaid cost and quality by December 2020 that examines its performance over time and compares it to other state Medicaid programs, and
- Convene an advisory board to provide input to the agency on reporting content and goals.
The executive orders precede the upcoming 2020 legislative session, during which the governor and state legislators are expected to submit additional bills addressing health care costs.
Massachusetts Takes a Next Step in Health Reform: Addressing Affordability through Value
/in Policy Massachusetts Blogs, Featured News Home Care Coordination, Chronic and Complex Populations, Chronic Disease Prevention and Management, Cost, Payment, and Delivery Reform, Essential Health Benefits, Health Coverage and Access, Health IT/Data, Health System Costs, Maternal, Child, and Adolescent Health, Medicaid Managed Care, Medicaid Managed Care, Medicaid Managed Care, Physical and Behavioral Health Integration, Population Health, Primary Care/Patient-Centered/Health Home, Quality and Measurement, Total Cost of Care Benchmark, Value-Based Purchasing /by Trish RileyStates are incrementalists – enacting laws, amending them, and building on their successes – and that strategy is clearly visible in Massachusetts Gov. Charlie Baker’s bold and comprehensive legislative proposal, An Act to Improve Health Care by Investing in VALUE, announced last week.
Baker’s proposal calls on payers and providers to increase expenditures on primary and behavioral health care by 30 percent systemwide over the next three years while complying with the state’s cost growth benchmarks, administered by the state’s Health Policy Commission. Baker said his proposal “will change the way the system looks, works and operates,” by prioritizing preventative care and early intervention and managing chronic conditions before patients require costly emergency department services.
The proposal includes initiatives to implement those expanded investments, including changes in workforce policies and scope of practice laws. At the same time, the governor proposes strengthening enforcement of cost-growth benchmarks by authorizing financial penalties on those who exceed them.
Additional proposals tackle affordability by:
- Prohibiting surprise billing for emergency and unplanned services and establishing an out-of-network default rate pegged at a percentage of Medicare and limiting the use of facility fees;
- Advancing insurance market reforms to improve access for small businesses and examining the impact of the state’s law that merges the individual and small group market; and
- Building on last year’s efforts to rein in drug prices. The proposal subjects manufacturers of certain high-cost drugs to Health Policy Commission review, requires those manufacturers to participate in cost trend hearings, expands oversight of pharmacy benefit managers, and most significantly, imposes a penalty on manufacturers that increases a drug’s price by more than 2 percent over the consumer price index in any year.
The proposed legislation includes provisions that address telemedicine, the health information exchange, and investments in safety net providers – including plans to stabilize distressed community hospitals and health centers.
Insurers would also be required to maintain accurate provider directories and be required to cover, with no additional costs, same-day behavioral health visits. Urgent care clinics would also be required to offer behavioral health services.
“For far too long, primary and behavioral health care has not been at the forefront of our health care system,” said Marylou Sudders, Massachusetts’ secretary of the Executive Office of Health and Human Services. “While we know that changing the narrative will take time, we are committed to engaging in a multi-year, multi-pronged approach to create a cohesive system of behavioral health care and strong primary care in the Commonwealth.”
The governor’s bill now heads to the state Legislature where debate is expected to be lively. The National Academy for State Health Policy (NASHP) will track and report on developments. To learn more about the plan, NASHP is planning to host a webinar with Sudders, who also sits on the Health Policy Commission board, soon.
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 























































































































































